Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

[Clinical features of patients with Basedow Graves disease seen at a university hospital].

Lanas A, Díaz P, Eugenin D, González F, Cid P, Cordero F, Araya V, Liberman C, Barberan M, Gac P, Saldías N, Pineda P.

Rev Med Chil. 2017 Apr;145(4):436-440. doi: 10.4067/S0034-98872017000400003. Spanish.

2.

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.

Sanyal AJ, Boyer TD, Frederick RT, Wong F, Rossaro L, Araya V, Vargas HE, Reddy KR, Pappas SC, Teuber P, Escalante S, Jamil K.

Aliment Pharmacol Ther. 2017 Jun;45(11):1390-1402. doi: 10.1111/apt.14052. Epub 2017 Mar 29.

3.

The role of hepatitis E virus infection in adult Americans with acute liver failure.

Fontana RJ, Engle RE, Scaglione S, Araya V, Shaikh O, Tillman H, Attar N, Purcell RH, Lee WM; US Acute Liver Failure Study Group.

Hepatology. 2016 Dec;64(6):1870-1880. doi: 10.1002/hep.28649. Epub 2016 Jun 23.

4.

Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study.

Younossi ZM, LaLuna LL, Santoro JJ, Mendes F, Araya V, Ravendhran N, Pedicone L, Lio I, Nader F, Hunt S, Racila A, Stepanova M.

BMC Gastroenterol. 2016 Apr 4;16:45. doi: 10.1186/s12876-016-0438-z.

5.

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.

Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC; REVERSE Study Investigators.

Gastroenterology. 2016 Jun;150(7):1579-1589.e2. doi: 10.1053/j.gastro.2016.02.026. Epub 2016 Feb 16.

PMID:
26896734
6.

[Serum lipid levels in a group of cocaine dependent subjects in recent abstinence].

Massardo T, Araya V, Ibáñez C, Véliz J, Fernández R, Jaimovich R, Pallavicini J, Chandía R, Pereira K, Pereira J.

Rev Med Chil. 2015 Jun;143(6):697-706. doi: 10.4067/S0034-98872015000600002. Spanish.

7.

[Second Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistance].

Pollak F, Araya V, Lanas A, Sapunar J, Arrese M, Aylwin CG, Bezanilla CG, Carrasco E, Carrasco F, Codner E, Díaz E, Durruty P, Galgani J, García H, Lahsen R, Liberman C, López G, Maíz A, Mujica V, Poniachik J, Sir T, Soto N, Valderas J, Villaseca P, Zavala C.

Rev Med Chil. 2015 May;143(5):627-36. doi: 10.4067/S0034-98872015000500012. Spanish.

8.

Type 2 diabetes mellitus in patients with mild obesity: preliminary results of surgical treatment.

Lanzarini E, Csendes A, Gutierrez L, Cuevas P, Lembach H, Molina JC, Musleh M, Braghetto I, Papapietro K, Araya V, Lahsen R, Olguin P, Riffo A, Diaz E, Montt D, Marín L.

Obes Surg. 2013 Feb;23(2):234-40. doi: 10.1007/s11695-012-0780-3.

PMID:
23054574
9.

Endogenous thyroid-stimulating hormone and radioactive iodine uptake in normal subjects.

González P, Jaimovich R, Araya V, Massardo T, Carmona A.

Clin Nucl Med. 2012 Jun;37(6):584-6. doi: 10.1097/RLU.0b013e3182478d75.

PMID:
22614192
10.

Response-guided telaprevir combination treatment for hepatitis C virus infection.

Sherman KE, Flamm SL, Afdhal NH, Nelson DR, Sulkowski MS, Everson GT, Fried MW, Adler M, Reesink HW, Martin M, Sankoh AJ, Adda N, Kauffman RS, George S, Wright CI, Poordad F; ILLUMINATE Study Team.

N Engl J Med. 2011 Sep 15;365(11):1014-24. doi: 10.1056/NEJMoa1014463. Erratum in: N Engl J Med. 2011 Oct 20;365(16):1551.

11.

Transjugular intrahepatic portosystemic shunts.

Ortiz J, Feyssa E, Araya V, Campos S.

Liver Transpl. 2011 Dec;17(12):1485; author reply 1486. doi: 10.1002/lt.22428. No abstract available.

12.

An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation.

Hashemi N, Araya V, Tufail K, Thummalakunta L, Feyssa E, Azhar A, Niazi M, Ortiz J.

World J Hepatol. 2011 Jul 27;3(7):198-204. doi: 10.4254/wjh.v3.i7.198.

13.

Tc-99m-BrIDA hepatobiliary (HIDA) scan has a low sensitivity for detecting biliary complications after orthotopic liver transplantation in patients with hyperbilirubinemia.

Hopkins LO, Feyssa E, Parsikia A, Khanmoradi K, Zaki R, Campos S, Araya V, Tran H, Ortiz J.

Ann Nucl Med. 2011 Dec;25(10):762-7. doi: 10.1007/s12149-011-0523-x. Epub 2011 Aug 16.

PMID:
21845382
14.

Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.

Boyer TD, Sanyal AJ, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Gülberg V, Sigal S, Bexon AS, Teuber P; Terlipressin Study Group.

Liver Transpl. 2011 Nov;17(11):1328-32. doi: 10.1002/lt.22395.

15.

Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant.

Ortiz J, Feyssa EL, Parsikia A, Azhar A, Hashemi N, Campos S, Khanmoradi K, Zaki R, Balasubramanian M, Araya V.

Exp Clin Transplant. 2011 Apr;9(2):105-12.

16.

MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation.

Feyssa E, Ortiz J, Grewal K, Azhar A, Parsikia A, Tufail K, Hashemi N, Brady P, Araya V.

Transplantation. 2011 Apr 15;91(7):786-92. doi: 10.1097/TP.0b013e31820e014e.

PMID:
21304440
17.

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.

Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P; Terlipressin Study Group.

J Hepatol. 2011 Aug;55(2):315-21. doi: 10.1016/j.jhep.2010.11.020. Epub 2010 Dec 15.

18.

Paraparesis caused by transarterial chemoembolization: A case report.

Tufail K, Araya V, Azhar A, Hertzog D, Khanmoradi K, Ortiz J.

World J Hepatol. 2010 Jul 27;2(7):289-91. doi: 10.4254/wjh.v2.i7.289.

19.

Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case report.

Niazi MA, Azhar A, Tufail K, Feyssa EL, Penny SF, McGregory M, Araya V, Ortiz JA.

World J Hepatol. 2010 Apr 27;2(4):162-6. doi: 10.4254/wjh.v2.i4.162.

20.

Falsely elevated tacrolimus levels caused by immunoassay interference secondary to beta-galactosidase antibodies in an infected liver transplant recipient.

Knorr JP, Grewal KS, Balasubramanian M, Young N, Zaki R, Khanmoradi K, Araya V, Ortiz J.

Pharmacotherapy. 2010 Sep;30(9):954.

PMID:
20812435

Supplemental Content

Loading ...
Support Center